CD34 and acute myeloid leukemia: Furthermore, CD47, which upon interaction with SIRPα on circulating macrophages and dendritic cells inhibits phagocytosis to facilitate immune evasion of AML cells, is overexpressed in CD34+CD38− LSCs, conferring a survival advantage to AML stem cells [26,27,28].